Key result
IV magnesium sulfate overdose from medication error triggers sudden neurological deterioration and iatrogenic toxicity.
Why the study?
Iatrogenic magnesium toxicity following intravenous magnesium sulfate infusion due to medication errors poses clinical risks that require prevention strategies.
Case Report (n=1)
Medication errors in the preparation of intravenous magnesium sulfate can lead to severe iatrogenic magnesium toxicity and sudden neurological deterioration.
Answers are grounded in this paper and cite their sources.
Alerts to iatrogenic magnesium toxicity from IV preparation errors; leaves open evaluation of systemic safeguards in high-risk infusions.
A 65-year-old man being treated with radiotherapy and chemotherapy for recurrent colonic adenocarcinoma was admitted for management of hypokalaemia and hypomagnesaemia secondary to diarrhoea. He was treated with intravenous infusions of potassium chloride and magnesium sulfate. Following an infusion of magnesium sulfate, he experienced a sudden neurological deterioration. A CT of the head revealed no haemorrhage or evidence of acute ischaemic injury. Results of serum biochemistry later that day revealed an elevated magnesium level. Iatrogenic magnesium toxicity was suspected. Further discussions between the pharmacist and ward staff confirmed that a medication error had been made in the preparation of the infusion resulting in an overdose of intravenous magnesium.
No takes yet. Share an insight, caveat, or question.
Cavell et al. (2015) conducted a case report in Iatrogenic magnesium toxicity (n=1). Intravenous infusion of magnesium sulfate was evaluated on Sudden neurological deterioration and iatrogenic magnesium toxicity. An overdose of intravenous magnesium sulfate due to a medication error resulted in sudden neurological deterioration and iatrogenic magnesium toxicity in a 65-year-old man.
Synapse has enriched 10 related papers. Consider them for comparative context: